Aster DM Healthcare Limited has issued an important clarification regarding its recent media announcement about a proposed healthcare development project in Kerala. The clarification, filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, addresses the company's December 18 media release.

Project Details and Clarification

The clarification pertains to the media release titled "Aster DM Healthcare announces ₹125 crore healthcare development project in Kottakkal, Kerala" issued by the company on December 18. The proposed investment is planned for Kottakkal, Kerala, representing a significant healthcare infrastructure development initiative.

Corporate Approval Requirements

The company has emphasized that the announced proposal is subject to obtaining relevant corporate approvals before proceeding. The required approvals include:

• Approval of the Board of Directors of Aster DM Healthcare Limited
• Approval of the Board of Directors of Malabar Institute of Medical Sciences Limited (subsidiary)

Aster DM Healthcare has committed to making further disclosures as appropriate once requisite corporate approvals are obtained for the proposed investment, in terms of Regulation 30 of the Listing Regulations and other applicable provisions.

Regulatory Compliance and Communication

The clarification document was addressed to both the BSE Limited and The National Stock Exchange of India Limited on December 20. The company stated that this clarification is issued in the interest of transparent communication with stakeholders, advising investors and market participants to take note of the approval requirements.

The clarification was signed by Hemish Purushottam, Company Secretary and Compliance Officer, emphasizing the company's commitment to regulatory compliance and stakeholder transparency regarding the proposed healthcare development project.

Aster DM Healthcare , a prominent healthcare provider, has received approval to shift its registered office from Karnataka to Telangana, marking a significant corporate move. The Regional Director (South East Region) of the Ministry of Corporate Affairs granted the approval on November 18, 2025, allowing the company to relocate its base to Hyderabad.

Key Details of the Relocation

Reasons for Relocation

Aster DM Healthcare cited several strategic reasons for this move:

1. Better administrative convenience
2. Improved operational efficiency
3. Enhanced business integration
4. Seamless implementation of company schemes

Regulatory Compliance

The company has stated that it is in the process of making necessary intimations and filings with the Registrar of Companies and other statutory authorities, as required by law. This move also entails a consequent alteration in the company's Memorandum of Association to reflect the change in registered office location.

Next Steps

Following this approval, Aster DM Healthcare is expected to complete the relocation process and update all relevant stakeholders, including shareholders, regulatory bodies, and business partners, about the change in its registered office address.

This strategic relocation underscores Aster DM Healthcare's commitment to optimizing its operations and potentially signals a focus on expanding its presence in the Telangana region.